T Cell News and Research

Latest T Cell News and Research

Research provides better understanding of how some cancer cells resist treatment

An international team of researchers led by Lucio Miele, MD, PhD, Professor and Chair of Genetics at LSU Health New Orleans School of Medicine, and Justin Stebbing, BM BCh MA, PhD, Professor of Cancer Medicine and Medical Oncology at Imperial College of Medicine in London, has found new genetic mutations that promote the survival of cancer cells.

23 Mar 2018

Researchers probe RNA epigenetics and chromatin structures to predict drug resistance in leukemia

Drug resistance is a major obstacle to effective treatment for patients with cancer and leukemia. Epigenetic modifying drugs have been proven effective for some patients with hematologic malignancies, such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML).

23 Mar 2018

Genetic mutation that may protect people from malaria found to be more common

A genetic mutation that may protect people from malaria, but was thought to be rare, is surprisingly common, suggest the findings of a new study led by scientists at The Scripps Research Institute.

23 Mar 2018

Restoring enzyme may help reverse effects of vascular aging, study shows

As people age, their blood-vessel density and blood flow decrease, which is why it's harder to maintain muscle mass after 40 and endurance in the later decades, even with exercise.

23 Mar 2018

What gives the curl to curly hair? Sheep wool provides clues

There has been no research that explains what gives the curl to curly hair. To understand this, the researchers looked at the microscopic structure of the hair and measure the individual hair cells in the curly hair that could explain the curls. However human hair was found to be too thick for these experiments. So as a next step they looked at naturally curly hair or wool from six Merino sheep from New Zealand. This provided them with the answers they were looking for. The study results were published this week in the latest issue of the Journal of Experimental Biology.

23 Mar 2018

Mice getting a new lease of life with anti-aging pills

According to a new study from the researchers at Harvard Medical School and the University of New South Wales, the actually cellular processes that cause aging of the blood vessels have been understood.

23 Mar 2018

New study identifies key cellular mechanisms behind vascular aging in mice

We are as old as our arteries, the adage goes, so could reversing the aging of blood vessels hold the key to restoring youthful vitality? The answer appears to be yes, at least in mice, according to a new study led by investigators at Harvard Medical School.

22 Mar 2018

New findings could have revolutionary impact on quality of life of older people

Researchers from UNSW and Harvard Medical School have discovered that replacing two naturally occurring molecules in the body could reverse symptoms of aging, potentially influencing how the body responds to and performs exercise.

22 Mar 2018

New computational method helps to identify tumor cell mutations with greater accuracy

A new computational method developed by researchers at the New York Genome Center allows scientists to identify rare gene mutations in cancer cells with greater accuracy and sensitivity than currently available approaches.

22 Mar 2018

Researchers make key discovery about cellular pathway linked to myriad of diseases

Researchers from the University of Dundee and the Francis Crick Institute have made a significant discovery about a cellular pathway associated with developmental defects and a myriad of diseases ranging from alopecia to colorectal cancer.

22 Mar 2018

Researchers find investigational compound to treat triple negative breast cancer after brain metastasis

Researchers at Houston Methodist used computer modeling to find an existing investigational drug compound for leukemia patients to treat triple negative breast cancer once it spreads to the brain.

22 Mar 2018

Researchers propose alternative treatment to target lymphoma signaling at its root

Non-Hodgkin lymphomas are cancers that affect white blood cells of the immune system called B-lymphocytes or B cells. Like cells in all cancers, the B cells begin to grow out of control, creating tumors in the lymph nodes, spleen or other tissues. In 2010 alone, it was estimated that non-Hodgkin lymphomas caused 210,000 deaths worldwide.

22 Mar 2018

Newly designed three-part molecule shows promise to treat breast cancers

A newly designed three-part molecule could be the one answer patients with a certain form of breast cancer are looking for, scientists report.

22 Mar 2018

Gut microbiome may promote pancreatic cancer by inducing immune suppression

Bacterial load was significantly higher in pancreatic tumor samples from patients with pancreatic ductal adenocarcinoma compared with pancreatic tissue from normal individuals, and in studies using mice, eliminating certain "bad" bacteria slowed the growth of pancreatic cancer, reversed immune suppression, and upregulated the immune checkpoint protein PD1.

22 Mar 2018

Researchers prove link between common childhood cancer and inflammation

The team of María Domínguez, researcher for the Neuroscience Institute, joint venture of the Miguel Hernández University in Elche and the Spanish National Research Council, has managed to prove for the first time that an important factor in the development of acute pediatric lymphoblastic leukemia is inflammation.

22 Mar 2018

Neem Biotech to share findings on cystic fibrosis biofilm disruption at ECFS Basic Science Conference

Neem Biotech, a Wales-based R&D biotech working in the field of novel antimicrobial drug development, announced today that it will be presenting results of its ongoing development work into the impact of NX-AS-401, its lead candidate,on biofilms in chronic cystic fibrosis lung infections at the 15th European Cystic Fibrosis Basic Science Conference taking place from 21st to 24th March 2018 in LoutrakiKorinthias, Greece.

From Neem Biotech 22 Mar 2018

Immunotherapy combination increases overall survival in people with kidney cancer, study shows

Treating people with advanced metastatic kidney cancer using a combination of the immunotherapy drugs nivolumab (Opdivo) and ipilimumab (Yervoy) significantly increased overall survival versus treatment with sunitinib (Sutent) alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center that were reported today in the New England Journal of Medicine.

22 Mar 2018

T Cell News and Research

Latest T Cell News and Research

Research provides better understanding of how some cancer cells resist treatment

Researchers probe RNA epigenetics and chromatin structures to predict drug resistance in leukemia

Genetic mutation that may protect people from malaria found to be more common

Restoring enzyme may help reverse effects of vascular aging, study shows

What gives the curl to curly hair? Sheep wool provides clues

Mice getting a new lease of life with anti-aging pills

New study identifies key cellular mechanisms behind vascular aging in mice

New findings could have revolutionary impact on quality of life of older people

New computational method helps to identify tumor cell mutations with greater accuracy

Researchers make key discovery about cellular pathway linked to myriad of diseases

Researchers find investigational compound to treat triple negative breast cancer after brain metastasis

Researchers propose alternative treatment to target lymphoma signaling at its root

Newly designed three-part molecule shows promise to treat breast cancers

Gut microbiome may promote pancreatic cancer by inducing immune suppression

Researchers prove link between common childhood cancer and inflammation

Neem Biotech to share findings on cystic fibrosis biofilm disruption at ECFS Basic Science Conference

Immunotherapy combination increases overall survival in people with kidney cancer, study shows

Targeting aberrantly active telomerase to treat therapy-resistant melanoma

TPP-related compounds selectively shut down cancer cells with little or no effect on healthy cells

Study: Lower temperatures can trigger the body’s ‘good’ fat formation at cellular level

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in